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ABSTRACT OF DISSERTATION
ELUCIDATING THE ROLE OF POLYCOMB REPRESSIVE COMPLEX 2
IN LUNG STEM CELL FATE AND LUNG DISEASE
The average human lungs take ~22,000 breaths and inhale ~2,000 gallons of air
each day. This organ is the primary conduit for the transfer of oxygen to the internal
organs, making it crucial for the sustainment of life. Consequently, mechanical
malfunction of the lungs and/or pollution of inhaled air negatively impact internal organ
function and ultimately put survival in jeopardy. Epigenetics, by nature, is a plastic
phenomenon in which environmental stimuli influence short term, long term, and
generational gene expression patterns. Chronic exposure of harmful stimuli to the lung
epithelium has also been shown to alter epigenetic pathways, engender aberrant lung cell
differentiation, and manifest into long term diseases. Chronic Obstructive Pulmonary
Disease (COPD) is a progressive, incurable lung disorder that is pathologically rooted in
chronic inflammation and aberrant lung cell differentiation. Polycomb Repressive
Complex 2 (PRC2) is a key epigenetic regulator of lung stem cell fate during
development, but little is understood of its role in adult lung. In the following chapters, I
will expound on how I utilized human patient samples, ex vivo lung organoids, and
murine in vivo models to better elucidate how PRC2 controls lung cell biology and offer
insight into potential therapeutic avenues to combat lung disease. To understand the role
of PRC2 in COPD, we first analyzed patient and control lung tissues. Using quantitative
immunohistochemistry and immunofluorescence, we observed a very significant
decrease in the Polycomb Repressive Complex 2 catalytic mark, histone H3 lysine 27 trimethylation (H3K27me3) in bronchiolar epithelium of COPD patients. Furthermore,
H3K27me3 staining was strongly inversely correlated with markers of basal and goblet
cells in patient samples. Next, we developed a new mouse model of conditional deletion
of the Polycomb Repressive Complex 2 enzyme, EZH2, and used this model to
interrogate lung stem cell function in organoid cultures and in vivo. Single cell RNAsequencing of organoid cultures revealed the appearance of Krt17-negative basal cells
and loss of the newly identified Krt8-positive progenitor cells in Ezh2-null cultures. Gene
signatures associated with immune response were increased is Ezh2-heterozygous
cultures, and genes enriched in EZH2 deficient organoids were enriched in human
emphysemic lung. Furthermore, when we used this Ezh2 conditional knock-out mouse
to interrogate the role of EZH2 in lung homeostasis and allergen response in vivo, we
found that Ezh2-heterozygous mice had increased response to ovalbumin allergen and
showed hallmarks of COPD including bronchiolar epithelial thickening and club to goblet
cell transdifferentiation. Lastly, we sought to learn the mechanism of decreased PRC2
activity in COPD patients. We used human bronchiolar epithelial cells to interrogate the
role of the redox-sensitive enzyme, cystathionine beta synthase (CBS), in controlling
EZH2 levels and gene expression modulation. In the patient samples, we found that CBS
was significantly higher in COPD lung. Excitingly, we identified shared transcriptional
profiles between human bronchiolar epithelial cells that over-express CBS and mouse
organoids with Ezh2 loss, offering insight into how redox stress may drive aberrant
epigenetic reprogramming. Taken together, these findings suggests that PRC2 is integral
to facilitating proper lung stem cell differentiation in adult humans and mice.
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CHAPTER 1. INTRODUCTION

1.1 Normal Lung Function
The average human lung is composed of five lobes. There are two lobes on the left side of the
body that are anatomically denoted as superior and inferior, and three lobes on the right side that
are denoted as superior, middle, and inferior. The lungs are further organized into proximal and
distal regions which also inform their mechanical functions. The conducting zone is positioned
closer to the proximal region of the body and facilitates airflow from the external environment and
deeper into the body. Conversely, the respiratory zone is positioned closer to the distal regions and
facilitates the transport of oxygen into and carbon dioxide out of the bloodstream [1].
The mechanical functions of the lungs inform its physiological structure, which can be
described as an inverted tree with numerous branches. The distal lung begins in the trachea, also
known as the windpipe. It is made of descending cartilage rings that connect to a posteriorly
positioned, thick band of smooth muscle known as the trachealis muscle [2]. The tracheal lumen
is lined with a mucous membrane that, along with a number of epithelial cells which will be
discussed later in the text, assists with maintaining moisture and protecting against harmful
xenobiotics [2]. At the base of the trachea is a ridge of cartilage called the carina that serves as the
branching point where the lungs divide into the left and right bronchi, appropriately denoted as the
primary bronchi [2]. As these passageways extend closer to the proximal regions of the lung, the
bronchi subdivide into more numerous and gradually narrower passageways [3]. The secondary
bronchi encompass the middle portion of the lung, while the tertiary bronchi encompass the
outermost regions of the lung [3, 4], In order to optimize mechanical expansion and contraction of
13

the lungs, as these channels progress deeper into the body, the amount of cartilage decreases while
the airway smooth muscle remains stalwart [5]. The end of the conducting zone is marked by the
final airway subdivisions known as the terminal bronchioles [4]. Consequently, the beginning of
the respiratory zone is marked by the final airway canals called respiratory bronchioles, which lead
into cylindrically oriented alveolar cells called alveolar ducts, and open into spherically oriented
alveolar cells which make up the alveolar sacs [4]. The alveolar sacs are the locations where
oxygen gathers and gas exchange occurs, via simple diffusion.

1.2 Normal Lung Epithelium
To deliver sufficient amounts of oxygen to the bloodstream, the lung epithelium must also be
sufficiently populated with stem cells that possess indefinite self-renewal and differentiation
capabilities, progenitor cells that possess finite self-renewal and varying differentiation
capabilities, and differentiated cells that have neither self-renewal nor differentiation capabilities.
The differentiated cells of the lung airways are goblet and ciliated cells [6]. Goblet cells are
colloquially termed as being simple columnar, meaning that they typically resemble an upright
column (columnar) and are positioned in a single layer (simple) along the basal lamina; a sheath
of connective tissue that line the airways. These cells produce and secrete mucins into the bronchial
lumen in order to bind and sequester inhaled pathogens, debris, and other small particles that don’t
belong in the lungs [6]. Ciliated cells, on the other hand, are pseudostratified columnar epithelial
cells, meaning that they’re positioned in a single cell layer along the basal lamina, but they appear
to be stacked atop one another. Ciliated cells are equipped with over 300 apically protruding cilia
that whip back and forth to move mucous and other debris up and out of the lungs [6, 7]. Ciliated
14

cells are present throughout the airways, including the respiratory bronchioles, but the number of
goblet cells gradually decreases as the lungs deepen [6, 8]. The differentiated cells in the lung
parenchyma are known as type I pneumocytes or alveolar type 1 (AT1) cells. These are squamous
cells (meaning they’re thin and flat) that interconnect to form a net-like configuration to make up
the alveolar sacs [4, 9]. Moreover, these sacs are enveloped in a labyrinth of capillaries to create
an air-blood barrier; effectively preventing the formation of air bubbles in the vasculature and the
transfer of blood into the lungs [9].
The progenitor cells in the lung airways are club (formerly known as Clara) cells; simple
columnar epithelial, secretory cells that play an essential role in lung detoxification [6, 10]. Their
primary secretion is the bioactive compound, secretoglobin 1A1 also known as club cell secretory
protein (CCSP), which have been shown to suppress inflammation, protect against xenobiotic
damage, and defend against bacterial infections [10]. Additionally, these cells express large
amounts of cytochrome P450 metabolizing enzymes, which function to increase the solubility, and
thereby excretion of harmful compounds like ozone, naphthalene, and elements of tobacco smoke
[10, 11]. The progenitor cells of the lung parenchyma are type II pneumocytes or alveolar type 2
(AT2) cells; cuboidal epithelial cells that secrete surfactants to reduce lung surface tension at the
air-water interface of alveolar sacs [12]. The progenies of AT2 cells are AT1 cells, while the
progeny of club cells are AT2, ciliated, and goblet cells.
Finally, the lung stem cells, from which all the aforementioned cells descended, are basal stem
cells (BSC) and bronchioalveolar stem cells (BASC). BSC are undifferentiated, simple cuboidal
epithelial cells that are capable of differentiating into club and goblet cells [6]. These cells are
typically enriched in the upper airways and decrease in number as the lungs deepen [13].
15

Alternatively, BASC are nonspecific, simple cuboidal epithelial cells that express both surfactant
(specifically, surfactant protein C [SP-C]) and CCSP [13]. Having only been characterized in
mouse lung, these unique cells reside at the junction between the respiratory bronchioles and the
alveolar ducts, appropriately coined the Bronchioalveolar-duct junction (BADJ) [13]. Intuitively,
their location and co-expression enable them to repopulate the bronchiolar airways with club cells
and the alveolar sac with AT2 cells.

1.3 Abnormal Lung Function and Epithelium
Due to the prevalence of harmful xenobiotics in the air and common respiratory infections, the
lung epithelium is primed for efficient self-repair. However, if the lungs are under chronic stress,
abnormal epithelial cell functioning ensues.

1.3.1

Lung Cancer

Lung cancer is the leading cause of cancer deaths in the world; killing more than 1.80
million people in 2020 [14]. Non-small cell lung cancers (NSCLC) accounts for 80-85% of all
cases while small cell lung cancer (SCLC) accounts for the remaining 10-15%. Cigarette smoke
exposure is the number 1 risk factor for all lung cancers; primarily attributable to the presence of
more than 60 carcinogens [15]. SCLC originates in lung neuroendocrine cells (epithelial cells that
receive neuronal input from the local environment and consequently secrete hormones into the
blood) and are typically found in the proximal bronchi [16]. It is also generally more aggressive
than NSCLC due to its high proliferative rate and strong predilection for metastasis [17].
Squamous cell carcinoma is a type of NSCLC that originates from the transformation of squamous
16

cells that line the airways, such as the trachea and main bronchi [18]. Adenocarcinoma is another
type of NSCLC that typically occurs in the proximal lung and develops in secreting epithelial cells,
such as goblet cells [19]. Finally, large cell carcinoma is an undifferentiated malignant tumor that
can develop in any part of the lung [20].

1.3.2

Pulmonary Fibrosis

Pulmonary Fibrosis (PF) is a fatal lung disease in which fibrotic tissue replaces the alveoli,
ultimately hindering ventilation and oxygen delivery to the bloodstream [21]. This disease affects
about 200,000 people nationwide [22], but it is often subject to late stage diagnosis, as the
symptoms are shared with other lung diseases [23]. Decades of research suggests that the
pulmonary fibrotic response is endorsed in three general stages- injury, inflammation and repair
[24]. Regardless of the various potential causes of PF [25, 26], the initial injury elicits production
of metal metalloproteinase (MMP) 2 and 9 from the epithelia and inflammatory cells, respectively
[27-29]. MMPs degrade surrounding ECM and enable leukocyte influx to- and efflux from the
damaged site [30-32]. Additionally, damaged epithelial cells and leukocytes up-regulate
chemokine production in an effort to stimulate the immune response. During the inflammatory
stage, there is a complex network of inflammatory cascades underway. Among these,
Transforming Growth Factor (TGF) β and Interleukin (IL) 4 dominate the fibrotic response by
directly activating myofibroblast transdifferentiation [33-35] and collagen deposition, respectively
[36, 37]. IL-4 also indirectly promotes myofibroblast transdifferentiation by activating TGFβ
production in M2 macrophages [38-40] and eosinophils [41]. The repair stage is the hallmark of
PF. It involves unrelenting myofibroblast transmigration to the alveolar space, collagen deposition,
and contraction [24].
17

1.3.3

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) claims over 3 million lives annually,
making it the third leading cause of worldwide deaths [42]. This progressive and irreversible
condition is presented as two, often overlapping, diseases; chronic bronchitis, a disease of longterm inflammation of the bronchi, and emphysema, a disease of persistent damage to and
destruction of the lung parenchyma. Cigarette smoke is the primary risk factor for COPD
development, as it promotes reactive oxygen species (ROS) production and subsequent
inflammation [43-45]. Nevertheless, respiratory infections [46] and long term exposure to
chemical fumes [47] air pollution [48, 49], and particulate matter [50] also promote its
development and progression. Individuals with COPD typically have multiple comorbidities [51],
with the largest contributors to death being respiratory failure [52], cardiovascular disease [53],
and lung cancer [54]. Cigarette smoke-induced ROS production, low grade inflammation, and
abnormal epithelial cell differentiation are all shared features between COPD and lung cancer [55].
Smokers with COPD are 3.5 times more likely to develop squamous lung cancer than smokers
with pathologically normal lung epithelium [56]. In a normal injury response, inflammation eventually
subsides, which allows for the initially hyperplastic epithelium to revert back to pseudostratified columnar
epithelium. However, in COPD lung, continual exposure to noxious agents perpetuates inflammation and
hinders epithelial resolution, so that even after the agent is removed, reversion still does not occur [57]. The
major epithelial changes observed in the COPD airway are basal and goblet cell hyperplasia, squamous
metaplasia, and mucin hypersecretion [58, 59]. Most recently, scRNA sequencing technology has allowed
for the discovery of rare stromal, immune and epithelial cell subpopulations present in diseased lungs [6065].
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1.4

Epigenetic Principles and Remodeling Factors

A genome is an organism’s complete set of DNA, and an epigenome is a set of chemical compounds
and proteins that influence genomic activity without changing its DNA sequence. In the nucleus, DNA is
highly coiled and organized into chromatin. Histones are basic proteins that enable this coiling by serving as
net-positively charged spools for the net-negatively charged DNA to wrap around. When DNA is wrapped
around a histone octamer (made of two H2A, H2B, H3 and H4 histones) and held in place by a histone H1
protein, it is called a “nucleosome”. This structure is plastic, allowing its components to be loosely or tightly
associated based on particular stimuli. The four ways to epigenetically, manipulate DNA is through
independent or interdependent RNA-mediated regulation, nucleosome remodeling, DNA methylation, and
histone modifications. RNA-mediated regulation occurs through a range of activities by small and long noncoding (lnc) RNA [66]. For example, microRNA (miRNA) inhibit gene expression by degrading genetic
transcripts [67], and lncRNA influence gene expression by recruiting additional epigenetic factors to particular
chromosomal regions [68]. Nucleosome remodeling is facilitated by the BRG1-Associated Factor (BAF)
complex. This multimer functions by either sliding or transporting histone octamers to effectively “activate”
(allow transcription factor access) or “silence” (prohibit transcription factor access) genes [69]. DNA
methylation silences genes and typically occurs at the 5’C of cytosines at CpG islands (a short stretch of DNA
in which the cytosine-guanine sequence is higher than other regions) within promotor regions. DNA
methyltransferase (DNMT) facilitates DNA methylation [70] while teneleven translocation (TET) enzymes
facilitate DNA de-methylation [71]. Finally, histones are post-translationally modified at specific amino acids
located on the N-terminal domain. The addition and/or removal of functional groups essentially serve as tags
to signal the recruitment of additional activating or silencing proteins [72]. Methyl groups can serve as both
an activating and silencing tag [73]. Histone methylation and demethylation is carried out by histone
methyltransferases (HMT) and histone demethylases (HDM), respectively. Moreover, these enzymes are
19

capable of mono- (me1) di- (me2) and tri- (me3) methylating/demethylating histones. While all histone tails
are capable of methylation [74-77] and all basic amino acids (histidine, arginine, and lysine) can be methylated
[78-80], lysine methylation on histone H3 (H3K) has been broadly studied. As a result, extensive
characterization of these alterations has led to strong associations between specific modification patterns and
transcriptional profiles. For example, mono-methylation of histone H3 on lysine 4 (H3K4me1) is an activating
mark that is commonly found at transcriptional enhancers [81], H3K9me2 is a repressive mark commonly
associated with silenced genomic regions [82], and H3K27me3 is a repressive mark that is commonly
associated with temporary control of developmental regulators [83] and often found in facultatively repressed
genes [84]. Most H3K targets have redundant HMTs [73], but H3K27me3 has only been linked to one highly
conserved HMT; Enhancer of Zeste Homolog 2 (EZH2) [85]. EZH2 is a 746 amino acid-long protein that
works alone or with other proteins to influence transcription. As a single entity, this enzyme acts as a
transcriptional activator by physically linking transcription factors with one another and their promoters [86,
87]. On the other hand, EZH2 acts as a transcriptional repressor by serving as the catalytic subunit that
facilitates H3K27me3 [13, 88, 89]. To carry out this repressive function, EZH2 interacts with two additional
proteins-EED and Suz12. EED serves as the scaffold protein that holds histone H3 and EZH2 together [13,
88, 89], and Suz12 has been implicated in serving as the “homing” subunit, which recognizes particular
nucleosomes for downstream action [90-93]. These three components make up what is called the Polycomb
Repressive Complex 2 (PRC2); an epigenetic multimer that maintains cellular specificity via repression of
unassociated genes. This complex is integral to homeostasis, as it maintains spatial and temporal gene
expression throughout an organism’s life. During embryonic development, the complex is crucial to stem cell
fate decisions, as it regulates repression of homeotic genes [94]. With age, EZH2 expression typically
decreases [95] and usually only increases to enable cell proliferation and survival [96]. Alternatively, PRC2
malfunction can bring about incongruous gene expression and result in diseases rooted in aberrant cell
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development [97-101]. Numerous cancers, for example, have been associated with repression of tumor
suppressor genes, as a consequence of increased EZH2 activity [96-102]. Conversely, loss of EZH2 activity
stifles lung endoderm development in mice due to its role in repressing lung stem cell-associated genes [103,
104]. Furthermore, recent unpublished data from the Brainson lab suggests that EZH2 activity underlies
chronic obstructive pulmonary disease (COPD), as a significant decrease in its function is associated goblet
cell hyperplasia in human lung. These findings suggest that improper PRC2/EZH2 activity is important for
cell development, fate, and function. They also warrant further investigation into EZH2’s role in disease
development and propagation, particularly those involving lung functions.

1.5

Role of Polycomb Repressive Complex 2 in Chronic Obstructive Pulmonary Disease
Pathology
Methyl group availability is integral to PRC2 activity, suggesting metabolic pathways could influence

PRC2 activity levels. Cystathionine Beta Synthase (CBS) is an enzyme that condenses serine and
homocysteine to produce cystathionine, an upstream precursor of glutathione (GSSH). GSSH has been
implicated in the mitigation of ROS production in COPD lung [105]. Post-translational modification analysis
on mouse and human cells treated with cigarette smoke showed the unique presence of mono- and dimethylated histone H3 lysine 27 that was not seen in controls, suggesting that cigarette smoke could lead to
decreased PRC2 activity [106]. However, a separate immunohistochemistry analysis of normal and COPD
lung showed a significantly higher number of tri-methylated histone H3 lysine 27 regardless of smoking status
[107].
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1.6

Technical Advances for 3-Dimendional Organoid Cultures

We are the first lab to use scRNA-seq to characterize the transcriptome of 3D cultured,
Ezh2 knockout mouse lung organoids. In the past, genome wide location analysis was employed
to characterize the transcriptome of 2D cultured, human embryonic fibroblasts following Ezh2
siRNA transfection [94]. Our choice to use the 3D spheroid model is based on previous literature
that demonstrates more physiologically relevant results compared to 2D cultures; specifically
regarding noticeable differences in differentiation and proliferation patterns, cell cross talk, and
comparable gene expression patterns to in vivo experiments [108].
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CHAPTER 2. MATERIALS AND METHODS

2.1

Mouse Cohorts

Mouse cohorts of Ezh2flox/flox,Ezh2flox/+, and Ezh2+/+ [109, 110] were all maintained in
virus-free conditions and bred to Teto:H2B-GFP, Rosa26:rtTA and Teto:Cre mice [111-113]. All
care and treatment of experimental animals were in accordance with University of Kentucky
Institutional Animal Care and Use Committee (IACUC) guidelines.

2.2

Ovalbumin Inhalation Model

Mice that ingested doxycycline water at 1mg/mL for approximately 4 months were used
for the following experiments. One mouse that did not receive doxycycline was included in the
Ezh2+/+ no-challenge cohort and was indistinguishable from the mice receiving doxycycline. After
4 months, cohorts were sensitized to ovalbumin by administering two doses of 20µg of ovalbumin
(SIGMA) in Imject Alum (#7761, Thermo Scientific) by intraperitoneal injection 3-5 days apart.
Approximately three weeks later, cohorts were challenged with either saline (control) or 2%
ovalbumin in saline (OVA) by aerosolizer for 30 minutes. Exactly 7 days after challenge, cohorts
were sacrificed and lungs were inflated with neutral buffered 10% formalin at 25cm gravity
pressure, tied off at the trachea, and allowed to incubate for at least 24 hours at room temperature
in 10% formalin. In the case that the gravity inflation did not work, lungs were carefully hand
inflated with formalin using a 27g needle and immediately placed into 10% formalin. After full
fixation, lungs were dissected by lobes, placed in cassettes, transferred to 70% ethanol, embedded
in paraffin, and sectioned at 4µm. Genotyping revealed that one non OVA challenged mouse,
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initially identified as Ezh2 wild type, had the presence of the Ezh2 floxed excised band, suggesting
the mouse had undergone heterozygous recombination in the germline, and was thus excluded
from the final analysis. Another non OVA challenged mouse was excluded from final analysis
due to advanced age relative to the rest of the cohort.

2.3

Patients Samples

Patient slides were provided by the Markey Cancer Center Biospecimen Procurement &
Translational Pathology Shared Resource Facility (BPTP SRF) of University of Kentucky. The
COPD tissue (n=10) was from routine lung reduction surgeries and the normal tissue (n=9) was
from biopsies of suspected lung cancers that were found to be non-cancerous. Patient tissues used
in this study were fully de-identified and do not constitute human subjects research. Samples were
initially selected for presence of enough intact bronchiolar tissue then sectioned at 4µm for
analysis.

2.4

Sorting of Murine Lung Cells

Mice were euthanized via intraperitoneal avertin or ketamine/xylazine injection followed
by thoracectomy, and lungs were injected with 2mL of dispase. All five lung lobes from one or
two genotype-matched donor mice were dissected from trachea and other tissues, were minced
with scissors and incubated in PBS, collagenase and dispase for 45 minutes. Tissues were strained
through 100- and 40 µm filters, then the cells were spun down and red cells were lysed in red blood
cell lysis buffer (0.15M NH4Cl, 10mM KHCO3, and 0.1mM Ethylenediaminetetraacetic acid).
Single cell suspensions were stained using rat-anti-mouse antibodies including anti-mouse-Sca124

APCCy7 (Fisher Scientific BDB560654), anti-mouse-EpCAM-PECy7 (BioLegend 118216), antimouse-CD31-APC (Fisher Scientific BDB551262) and anti-mouse-CD45-APC (Fisher Scientific
BDB559864). Live cells were gated by exclusion of 4',6-diamidino-2-phenylindole (DAPI)
positive cells (SIGMA). Cell sorting was performed with a Sony iCyt with a 100µm nozzle.
Following the sort, cells were subject to cytospin and immunofluourescent staining in order to
quantify the distribution of bronchiolar and alveolar cells (Figure 2.1). From this analysis, it was
revealed that a majority of the Sca1- cells were pro-SPC positive and lacked CCSP expression,
indicating their alveolar type 2 identity. The Sca1+ cells were a mixture of pro-SPC+, CCSP+ and
acetylated tubulin+ cells, with some cells co-expressing pro-SPC and CCSP. The number of
CCSP+ cells was significantly higher in Sca1+ cells compared to Sca1- (p=0.04).
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Figure 2.1

Murine-derived Sca1- and Sca1+ cell sort and quantification

A) Representative flow cytometry gating strategies for lung samples over time. After gating for
DAPIneg live cells and singlets, hematopoietic and endothelial cells were excluded and then
EpCAM+/Sca1- and EpCAM+/Sca1+ cells were gated for sorting. B) Cytospin images of
EpCAM+/Sca1- and EpCAM+/Sca1+ cells stained for the indicated cell lineage markers. Note
that speckles and blotches of non-specific stain (not associated with a DAPIpos nucleus) were
edited from images because they were artifacts of cytospin that would interfere with quantification
of cell types. Scale bar = 50µm. C) Graphs of percentages of DAPIpos cells that had staining for
each marker. Acetylated tubulin was only stained for in the EpCAM+/Sca1+ fraction. Mean ±
sem is graphed for n=4 independent lungs sorted. 9-11 4x images of the cytospins were used for
quantifications with the Nikon AR bright spot detection module. * indicates p=0.04 using 2-tailed
t- test with equal variance comparing Sca1- club cells to Sca1+ club cells.
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2.5

Murine Bronchiolar Organoid Culture

Bronchioalveolar stem (EpCAM+/Sca1+) and alveolar type 2 cells (EpCAM+/Sca1-)
were sorted from doxycycline naïve Ezh2-floxed mice. Cells were plated with neonatal mouse lung
endothelial cells in air-liquid-interface Matrigel cultures [114]. 3D media was composed of
DMEM-F12, fetal bovine serum (FBS), and insulin-transferrin-selenium (ITS). Doxycycline (100200 ng/mL) was added to the cultures approximately 5 days after plating. Cultures were passaged
as needed. Cultures with sufficient bronchiolar organoids were then dispased, collected,
trypsinized, sorted for GFP+ cells, and then seeded at equal densities to grow for an additional 2.54 weeks based on the growth rate of the cultures in each experiment. This experiment was repeated
5 times. Due to COVID19, the fifth experiment was not sorted, but rather the organoids were
allowed to sink by gravity in 1x PBS and the supernatant was removed in order to deplete the
endothelial cells prior to trypsinization. For the final analysis, one Ezh2 heterozygous culture that
was clearly cross-contaminated with an unknown GFP-negative cell type, and one Ezh2 null
outlier, that was determined through the ROUT method on GraphPad Prism graph 9, was excluded.
After the final 4-week growth period, fixed or fresh organoids were counted by eye on a
fluorescence microscope. Cultures were fixed with 10% neutral buffered formalin overnight at
room temperature (Experiments 1, 2, 3, and 5) or dispased to collect cells for GFP+ sorting for
scRNAseq (Experiment 4). For fixed cultures, after rinsing with 70% ethanol, fixed Matrigel plugs
containing the organoids were immobilized with Histogel (Thermo Scientific) on 10cm dishes,
counted again, and imaged at 4x magnification for size quantification prior to paraffin embedding.
For scRNA-seq, organoids were pooled by genotype prior to GFP resort. There were initially two
wild type donors, but further genotyping later revealed that one donor likely underwent
heterozygous recombination in germline. However, it is important to note that this particular cohort
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only accounted for 3% of total harvested wild type organoids, and the loxP recombination site
junction was undetectable in the ‘wild-type’ cells captured, but was detectable in the Ezh2 null and
heterozygous samples.

2.6

Single Cell RNA-sequencing

The sequencer produced Chromium single-cell data and then the Cell Ranger toolkit
version 3.1 (10X Genomics) was used to de-multiplex samples from raw sequencing reads to genecount matrices with alignment to the mm10 genome (v93). In order to perform the downstream
analysis, such as cell type identification and differential gene expression analysis, Seurat (V3) R
package [115] was employed to aggregate the gene-counts matrices from all samples and provide
the analytical insight. A five-step process was performed using Seurat package: (1) For quality
control and data pre-processing, we discarded genes expressed in fewer than three cells and
discarded the low-quality cells that had less than 100 genes expressed. We also assessed the
percentage of mitochondrial transcripts for each sample, and each of them indicated a low level of
expression (below 10%). The count matrices were then log-transformed. (2) For sample merging
and feature selection, we combined the log-transformed matrices of each sample and applied the
variance-stabilizing transformation (vst) method to remove cell-to-cell variation. The top 2000
genes were selected for downstream analysis. (3) For dimension reduction and clustering, we
applied “PCA” to reduce the dimensionality of the merged data to 50 principle components and
then performed a shared nearest neighbor (SNN) modularity optimization-based algorithm to
identify clusters of cells. We utilized the UMAP [116] technique to visualize the clustering results
as shown in Figure 3A. (4) For cell type identification, we created a dot plot (Figure 3B) using
42 cell type specific marker genes to understand the cell identities of each cluster. Cell cluster
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identities were also validated by examining highly expressed genes in each cell cluster as shown
in the heatmap (Figure S3). (5) For differential gene expression analysis for each cell population,
we used a DEG (Differential Expressed Gene) identification method in Seurat, namely “MAST”
[117], to identify the up/down-regulated sets of genes between a pair of Ezh2 genotypes within
each cell population. Other analytical results from Seurat were visualized in Figure 4 and S4. In
Figure 4A, the UMAP plot depicted a combined perspective of the three genotypes, and the violin
plots in Figure 4B showed how the expression of six gene markers varied across the three
genotypes. Furthermore, trajectory inference was performed on each genotype using Slingshot
(v2.0) [118] and the results were illustrated in Figure S4A. The UMAP plot illustrated a split view
of the three genotypes in contrast to the group view in Figure 3A. The nodes in the figure represent
centers of clusters and connections between these nodes are called lineages. The lineages of
adjacent cell populations indicated these cell populations were biologically relevant. In the Figure
4C, the distribution of cell clusters across genotypes was assessed by z-test and p values were
adjusted for multiple hypothesis testing.

2.7

RNA-sequencing

Human Bronchiolar Epithelial Cell RNA was extracted by Agilent Absolutely RNA kit
with a DNAse step performed on the columns. Library preparation and sequencing were performed
by the Beijing Genomics Institute (BGI Group) using DNBseq and 50bp single end reads.
Sequencing reads were trimmed and filtered using Trimmomatic (V0.39) [119] to remove adapters
and low quality reads. Reads from human samples were mapped to Ensembl GRCh38 transcripts
annotation (release 98), respectively, using RSEM [120]. Gene expression data normalization and
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differential expression analysis were performed using the R package edgeR [121]. Significantly
up/downregulated genes were determined as fold change ≥ 2 and q-value < 0.05.

2.8

Gene Set Enrichment Analysis

GSEA was performed with GSEA version 4.0.3 (Broad Institute) with rank-ordered gene
lists

generated

using

all

log-fold

change

values.

Mouse_Gene_Symbol_Remapping_Human_Orthologs_MSigDB.v7.4.chip was used to map
mouse genes to human orthologs. Databases queried included Hallmarks (h.all.v7.4), Curated
(c2.all.v7.4),

BioCarta

(c2.cp.biocarta.v7.4),

KEGG

(c2.cp.kegg.v7.4),

Reactome

(c2.cp.reactome.v7.4), Gene Ontology (c5.all.v7.4), Oncogenic Signatures (c6.all.v7.4), and
Immunologic Signatures (c7.all.v7.1). Gene signatures that converged on common themes were
selected for further analysis and graphing of enrichment scores and FDRs for specific contrasts.
CBS overexpression vs empty vector HBEC gene list was generated based on adjusted p value
<0.05 and LFC >1. Null vs wild type, and heterozygous vs wild type Krt17- basal cell gene lists
were generated based on adjusted p value <0.05. For comparison to the emphysema signatures,
data were accessed from GEO under accession number GSE1650 and processed using R with affy
and limma packages and rma normalization. The moderated t-statistic was used to produce the
rank ordered gene list comparing emphysemic smokers to healthy smokers, noting that emphysema
is one of the hallmarks of COPD.
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2.9

Immunofluorescence and Quantification

All sections were deparaffinized and subjected to antigen retrieval in citrate buffer pH 6.0
with the Lab Vision™ PT module (Thermofisher) machine. Patient derived tissue sections were
blocked with 10% Donkey serum (Jackson ImmunoResearch, #017-000-121) in PBS-TritonX and
immunostained with antibodies for CCSP (R&D systems, #MAB4218,1:150), Keratin 5
(Biolegend, #905501,1:200), and MUC5AC (AbCAM, #AB3649,1:100) in a humid chamber
overnight at 4°C. Secondary Antibody staining included donkey anti-rat Alexa Fluor 488
(#A21208), donkey anti-rabbit Alexa Fluor 647 (#A31573), and donkey anti-mouse Alexa Fluor
594 (#A21203) (Invitrogen,1:200). Nuclei were stained with ProLong Gold with DAPI
(Invitrogen, #P36935). Mouse organoids and whole lung tissue sections were immunostained with
antibodies for CCSP (Millipore, #ABS1673,1:100), KRT5 (Biolegend, #905501,1:200),
Acetylated tubulin (SIGMA, #T7451,1:1000), and pro-SPC (Millipore, #AB3786,1:200).
Secondary antibody staining included donkey anti-goat Alexa Fluor 488 (#A11055), donkey antirabbit Alexa Fluor 647 (#A31573), donkey anti-mouse Alexa Fluor 594 (#A21203)
(Invitrogen,1:200). Nuclei were stained with ProLong Gold with DAPI (Invitrogen, #P36935).
Stain imaging was conducted on Nikon Eclipse inverted microscope using 20x objective and
quantification was conducted with the Nikon NIS-Elements AR software, respectively. For
quantification of lungs, blinded 20x images were obtained on one exposure and NIS-Elements was
used to quantify each batch using equivalent settings. For quantification of organoids, 20x images
were matched to H&E stains and LUTs were set by image batch due to differing staining
intensities. Organoid type and cell number quantifications were done blinded by eye. Organoids
with characteristics difficult to interpret on the original image were further analyzed by microscopy
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to ensure correct classification. Squamous types were classified as such if morphological
characteristics were present in at least part of the organoid.

2.10

Alcian Blue Staining and Quantification

Alcian Blue staining of whole mouse lung was performed by the Biospecimen Procurement
& Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer
Center. Representative images of bronchus from each mouse stained were captured in a blinded
fashion and were used to measure Alcian Blue cell number and area and epithelium lengths with
the HALO® 3.2 software (Indica Labs).

2.11

Immunohistochemistry and Quantification

Antigen retrieved patient derived tissues were blocked with 3% hydrogen peroxide for 10
minutes at room temperature, washed with PBS, then blocked with goat serum (Vectastain® ABC
Kit, PK-6101) in PBS-TritonX. Tissues were immunostained with antibodies for H3K27me3 (Cell
Signaling, #9733,1:500), EZH2 (Cell Signaling, #5246S,1:300), and CBS (Novus, #NBP183255,1:250) in a humid chamber overnight at 4°C. Secondary antibody, biotinylated rabbit
antibody (Vectastain® ABC Kit, PK-4001), was incubated for 30 minutes at room temperature.
Tissues were incubated in ABC reagent (Vectastain® ABC Kit, PK-4001) for 30 minutes at room
temperature, washed in PBS, then submerged in DAB (Vectastain® ABC Kit, SK-4100) solution
and counter-stained with Harris’ Hematoxylin (Electron Microscopy Science, #26754-01) prior to
mounting. Scoring of H3K27me3 (Cell Signaling, #9733) and EZH2 (Cell signaling, #5246S)
nuclear staining was performed with Nikon NIS-Elements AR software. 20x magnification images
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were captured of bronchiolar epithelial regions. The bronchiolar regions were gated by hand, prior
to using the NIS dot detection module to quantify stained nuclei with increasing stringency on the
blue channel. The user confirmed the correct counting of nuclei and the cutoffs for DAB signal
for each set of images prior to running the macro on all batched images. Percentage of positive
nuclei were quantified and graphed for each cutoff.

2.12

Western Blotting

Whole cell extracts were made in RIPA buffer (0.5% Deoxycholate, 1% IGEPAL-CA630,
0.1% sodium dodecyl sulfate, 150mM NaCl, 50mM Tris-8.1) with Halt™ Protease and
Phosphatase Inhibitor (Thermo) and with or without additional 1mM DTT, lysates were cleared
by centrifugation, and protein concentrations were quantified with the Pierce BCA Protein Assay
Kit (Thermo Fisher, #23225). For Western blotting, concentration matched samples were
denatured with heat and reducing agents, split into identically loaded lanes, separated on a 4-15%
acrylamide gel (BioRad) and transferred to nitrocellulose membranes (GE Healthcare,
#10600002). Antibodies used for Western blotting were: EZH2 (Cell Signaling, #5246s, 1:1000),
H3K27me3 (Cell Signaling, #9733s, 1:1,000) and CBS (Cell Signaling, #14782s, 1:1,000) all
incubated at least 18 hours at 4ºC. Histone H3 (Abcam, #ab1791, 1:5,000) was used as loading
control run on a blot with 1/3 the concentration of the primary blot diluted from the same samples
and run simultaneously. Secondary anti-rabbit IgG, HRP-linked antibody (Novus, #NB7160,
1:10,000) was incubated for 1 hour at room temperature. After washing, chemiluminescence was
visualized with Super-signal West Pico PLUS Chemiluminescent Substrate (Thermo) and
exposure onto Hyperfilm (Amersham). Western Blot quantification was performed with the Gel
Analysis tools in ImageJ.
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2.13

Human Bronchiolar Epithelial Cultures

Human Bronchial Epithelial Cell (HBEC) lines were donated from the David Orren Lab at
the University of Kentucky and were authenticated by IDEXX laboratories using CellCheck9.
HBECs were initially grown in PneumaCult™-EX media, on gelatin coated plates and transduced
with viral supernatant for 4-6 hours, then maintained in PneumaCult™-EX media for 4-5 days.
Cells were then transferred onto gelatin coated 10cm plates and selected for with PneumaCult™EX media + 1µg/mL Blasticidin (Gibco, A1113903) for 4-5 days and then passaged for
experiments.

2.14

Viruses

The human CBS open reading frame (ORF) was purchased from Origene (RC201755).
The ORF was amplified by PCR with proof reading polymerase (Agilent 600385-51) and cloned
into pENTR™/D-TOPO™ Vector (Thermo) and then flipped into pLenti6⁄V5-DEST® Gateway®
(Thermo). Vectors were maintained and amplified in One Shot® Stbl3™ Chemically Competent
E. coli (Thermo). pLenti6-CBS lentivirus or pLenti6 were packaged in HEK293T cells with a
lipofectamine, VSVG, VPRΔ8.2 vector system [122].

2.15

Statistical Analysis

Statistical analyses were carried out using GraphPad Prism or Microsoft Excel. Unless
otherwise stated, all numerical data are presented as mean ± standard error of the mean. To
compare continuous outcomes between two experimental groups, data with sufficient n were tested
for normality using Kolmogorov-Smirnov test. For normally distributed data and data with small
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n, an unpaired 2-tailed t-test with equal variance was used, and for data that failed the normality
test, a Mann-Whitney U test was used as indicated in the figure legends. For grouped analyses,
simple one-way ANOVA with Holm’s multiple comparison correction was used when all the
values of one group were the same, while Brown-Forsythe and Welch ANOVA tests with GamesHowell’s multiple comparison correction was used for all other tests. Pearson’s Correlation was
used to test the linear relationship between markers. A p value (or adjusted p value) less than 0.05
was considered statistically significant.

2.16

Data Availability

The single cell RNA-sequencing data for study are available at the NCBI GEO database
under GSE184347, the bulk RNA-sequencing are available at the NCBI GEO database under
GSE183858. The data that support the findings of this study are available from the corresponding
author upon reasonable request.
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CHAPTER 3. PATIENT DERIVED TISSUES SHOW DRAMATIC REDUCTION IN
H3K27ME3 IN COPD BRONCHIOLAR CELLS
Chronic Obstructive Pulmonary Disease (COPD) is a progressive, lethal disease that
hinders respiration at the lung’s conducting and respiratory zones. This disease is characterized by
chronic bronchitis, excessive airway mucus deposition, and profuse inflammatory cell infiltration
into the lung airway and alveoli [123]. Given these deleterious effects, it is important to elucidate
the molecular mechanisms that drive COPD, and to understand why, even when environmental
factors such as cigarette smoke are removed, COPD persists. EZH2 is the subunit within the PRC2
complex that tri-methylates histone H3 at lysine 27 (H3K27me3), marking DNA for transcriptional
silencing and allowing expression of a single transcriptional profile [124]. Furthermore, loss of
PRC2 leads to aberrant basal cell gene expression in distal airways of embryonic mouse lungs,
suggesting its role in determining proper bronchiolar cell differentiation [103, 104].

3.1

COPD bronchiolar epithelium exhibit significant reduction in H3K27me3

To understand the relationship between PRC2 activity and the COPD phenotype, we
obtained 10 COPD and 9 normal lung tissue samples (Tables 3.1-3.2) and stained sections for
EZH2, the catalytic mark of EZH2, histone H3 lysine 27 trimethylation (H3K27me3), KRT5, a
basal cell marker, MUC5AC, a goblet cell marker, and CCSP, a club cell marker (Figure 3.1; 3.3).
Using quantitative measurement of immunostaining intensity, there was a striking and very
significant reduction of H3K27me3 mark in the nuclei of bronchiolar epithelial cells in COPD
lung relative to normal controls (p=0.003, Figure 3.2B-C). This finding was supported by results
from an independent immunohistochemistry experiment conducted on cross-sections from a
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different level of the tissue blocks (Figure 3.2A). In these same tissues, there were no differences
in EZH2 expression between the normal and disease state (Figure 3.2D).
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Table 3.1

Patient Derived Tissue Demographics
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Table 3.2

Extended Patient Demographics
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Figure 3.1

Representative images of H3K27me3 and EZH2 immunohistochemistry stains of

normal and COPD lung, scale bar = 100µm.
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Figure 3.2

H3K27me3 and EZH2 Immunohistochemistry Analysis

A) Average percentage of epithelial cells expressing varying levels of H3K27me3 in normal (n=5)
and COPD (n=10) patient derived lung tissues, * indicates p<0.05 using 2-tailed t- test with equal
variance. B) Average percentage of epithelial cells expressing varying levels of H3K27me3. *
indicates p<0.05 and ** indicates p<0.01 with a 2-tailed Mann-Whitney U with equal variance
comparing Normal to COPD. C) Average percentage of epithelial cells expressing high levels of
H3K27me3, ** indicates p<0.01 with a 2-tailed t-test with equal variance comparing Normal to
COPD. D) Average percentage of epithelial cells expressing EZH2 in human lung.
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3.2

Reduced lung H3K27me3 significantly correlate with increased basal cell
hyperplasia and club-goblet cell transdifferentiation

Next, we quantified several parameters of the KRT5, MUC5AC and CCSP
immunofluorescence staining and correlated these results with H3K27me3 expression levels.
There was a strong negative correlation between the percentage of epithelial cells with high
H3K27me3 and the area of KRT5 expression (Pearson’s Correlation=-0.57, p=0.01 Figure 3.5A).
Similarly, the area of MUC5AC+ epithelia were also significantly negatively correlated with the
percentage of H3K27me3-high cells (Pearsons’s Correlation=-0.53, p=0.02, Figure 3.5B).
Evaluation of co-localized CCSP/MUC5AC expression showed that the percentage of double
positive cells were strongly inversely correlated with the percentage of H3K27me3-high cells
(Pearson’s Correlation=-0.50, p=0.03, Figure 3.5C).

3.3

COPD bronchiolar epithelium exhibit dramatic increase in basal, club and goblet
cell lineage genes
Analysis between disease states revealed that more than 70% of MUC5AC+ cells in COPD

lung had co-localized CCSP expression, whereas only 30% of MUC5AC+ cells in normal lungs
co-expressed CCSP (p=0.01, Figure 3.4B). Furthermore, COPD lung exhibited a significantly
higher numbers of MUC5AC+ cells compared to normal (Figure 3.4A). Together these data show
that EZH2 function is significantly diminished in COPD lung, and this loss correlates with aberrant
lung cell fate.
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Figure 3.3

Representative images of immunofluorescent stains of normal and COPD lung

from three different patients, scale bar = 100µm.
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Figure 3.4

Immunofluourescence analysis of normal and COPD lung

A) Average number of epithelial cells expressing MUC5AC * indicates p=0.03 using 2-tailed ttest with equal variance. Analysis was performed on at least 4 separate, 20x images. B) Average
percentage of epithelial cells that co-express MUC5AC and CCSP, * indicates p=0.01 with a 2tailed Mann-Whitney U with equal variance.
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Figure 3.5

Correlation

analysis

of

H3K27me3

immunohistochemistry

and

immunofluorescences stains on normal and COPD lung.
A) Correlation between high H3K27me3 expression and KRT5+ area within the epithelium
(Pearson’s Correlation= -0.57, p=0.01). B) Correlation between high H3K27me3 expression and
MUC5AC+ area within the epithelium (Pearson’s Correlation= -0.53, p=0.02). C) Correlation
between high H3K27me3 expression and the percentage of cells that co-express MUC5AC and
CCSP (Pearson’s Correlation= -0.50, p=0.03). Correlation Analysis was conducted by Alexsandr
Lukyanchuk.
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3.4

Increased lung CBS significantly correlates with increased club-goblet
transdifferentiation

Both Cystathionine Beta Synthase (CBS) and PRC2 activity are modulated in the wake of
cigarette smoke-induced reactive oxygen species production [105, 125]. To elucidate if CBS is a
potential upstream modulator of PRC2 activity, we conducted immunohistochemistry stains on
COPD and normal human tissues (Figure 3.6). We found that COPD bronchiolar epithelial cells
exhibited significantly more CBS expression compared to normal bronchiolar cells, and that
COPD cells often showed nuclear staining of CBS (p=0.002, Figure 3.7). Next, we conducted
correlation analysis between CBS expression and the immunofluorescence stains for MUC5AC,
CCSP and KRT5. We observed a significant positive correlation between the percentage of CBS+
cells and the percentage of CCSP+/MUC5AC+ cells (Pearson’s Correlation=0.63, p=0.004,
Figure 3.8). Next, to determine if CBS expression was a direct upstream target for PRC2
inhibition, we overexpressed CBS in Human Bronchial Epithelial Cells (HBECs) and grew them
as 2D cultures. Western Blot analysis showed that significant overexpression of CBS (P=0.0001)
led to a significant decrease in both EZH2 and H3K27me3 expression (P=0.001, p=0.0003, Figure
3.9). These data demonstrate that CBS may alter lung epithelial cell fate towards a more PRC2depleted state, leading to the aberrant cellular differentiation seen in COPD patients.
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Figure 3.6

Representative

images

of

Cystathionine

immunohistochemistry stains on normal and COPD lung.
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Beta

Synthase

(CBS)

Figure 3.7

Analysis of Cystathionine Beta Synthase (CBS) immunohistochemistry stains on

normal and COPD lung. * indicates p=0.0024 using 2-tailed t-test with equal variance
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Figure 3.8

Correlation analysis of Cystathionine Beta Synthase (CBS) immunohistochemistry

and immunofluorescence stains on normal and COPD lung. Correlation Analysis was conducted
by Alexsandr Lukyanchuk.
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Figure 3.9

Cystathionine beta synthase western blot analysis

A) RT-qPCR for CBS transcript in the three biological replicate HBEC3KT cultures, n=3. ***
indicates p=0.0001 using 2-tailed t- test with equal variance. B) Western blot images from three
biological replicate experiments (new infection and selection) of HBEC3KT with control virus
(EV) or virus over-expressing CBS. H3 is the loading control. C) Quantification of three
independent Western blots for each biological replicate, n=9. **** indicates p<0.00001 using 2tailed t- test with equal variance. ** indicates p=0.001 using 2-tailed t- test with equal variance.
*** indicates p=0.0003 using 2-tailed t- test with equal variance. Western blot analysis was
conducted by Kassandra Naughton.
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Figure 3.10

Correlation Plots of normal and COPD patient derived tissues

Pearson’s Correlation table showing the relationship between varying bronchial epithelial cell IF
stains and expression of H3K27me3 and CBS in normal (n=9) and COPD (n=10) lung.
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CHAPTER 4. EZH2 DEPLETED ORGANOIDS HAVE DECREASED SELF-RENEWAL
AND INCREASED SQUAMOUS MORPHOLOGY
EZH2 is a 746 amino acid-long protein that works alone or with other proteins to influence
transcription. Within the Polycomb Repressive Complex 2 (PRC2), EZH2 acts as a transcriptional
repressor by facilitating H3K27me3 [13, 88, 89]. PRC2 is integral to homeostasis, as it maintains
spatial and temporal gene expression throughout an organism’s life. During embryonic
development, this complex is crucial to stem cell fate decisions, as it regulates repression of
homeotic genes [94]. With age, EZH2 expression typically decreases [95] and usually only
increases to enable cell proliferation and survival [96]. Alternatively, PRC2 malfunction can bring
about incongruous gene expression and result in diseases rooted in aberrant cell development [97101]. Conversely, loss of EZH2 activity stifles lung endoderm development in mice due to its role
in repressing lung stem cell-associated genes [103, 104]. These findings suggest that improper
PRC2/EZH2 activity is important for cell development, fate, and function.

4.1

3-Dimensional organoid culture analysis elucidates the effects of dose dependent
gene expression in vitro
In order to have temporal control over Ezh2 expression in adult mice, we bred mice that

possessed conditional floxed alleles of Ezh2 with mice that possessed a tetracycline response
element followed by Cre gene (Figure 4.1). These mice also have a reversible tetracycline transactivator under the control of the ubiquitously and constitutively expressed Rosa26 promoter. With
this model, Ezh2 was intact until doxycycline was administered via tissue culture media.
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Figure 4.1

Mouse organoid treatment schematic

Schematic: Mouse bronchioalveolar stem cells (BASC) and alveolar type 2 cells were isolated,
using fluorescence activated cell sorting (FACS), from doxycycline naïve mice that had no, one or
two floxed alleles of Ezh2. Cells were cultured in air-liquid-interface Matrigel with neonatal mouse
lung endothelial support cells. After organoids were established, the cells were switched to
doxycycline media. Organoids were grown and passaged for approximately 5 weeks, then seeded
at equal densities to grow for an additional 2.5-4 weeks based on the growth rate of the cultures in
each experiment.
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Figure 4.2

Mouse organoid genotype verification

Gel electrophoresis of Ezh2 wild-type, heterozygous, and null organoids showing efficient
recombination of Ezh2 expression after doxycycline treatment. The Ezh2 wild type bands present
in the null lanes are from the co-cultured, mouse lung endothelial support cells which are Ezh2
wild-type.
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4.2

Ezh2 null organoids lose self-renewal and replication capabilities

To understand how Ezh2 expression alters mouse stem cell fate in culture, doxycycline was
added to the media several days after cell seeding when primitive organoids had formed. Organoids
were grown and passaged as needed in 3D culture, and at approximately 5 weeks of culture were
seeded at equal densities to grow for an additional 2.5-4 weeks (Figure 4.1). We reasoned that
this was sufficient time for loss of PRC2 activity to influence lineage fate decisions. We confirmed
that Ezh2 was excised in these cultures by PCR (Figure 4.2). From these final cultures, the number
of Ezh2 null organoids were significantly lower compared to Ezh2 wild-type cultures (p=0.0047)
(Figure 4.3). The diameter of Ezh2 null organoids were significantly smaller than wild type when
each organoid was considered a biological replicate, but not when averaged sizes per donor were
compared (Figure 4.4).
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Figure 4.3

Mouse organoid count analysis

Average number of organoids represented of Ezh2 wild type (n=7), heterozygous (n=10) and null
(n=9) mouse donors, ** indicates p=0.0047 between Ezh2 wild-type and Ezh2 null organoids using
ANOVA.
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Figure 4.4

Mouse organoid diameter analysis

A) Average diameter of Ezh2 wild-type (n=6), heterozygous (n=5), and null (n=4) organoids per
donor. B) Average diameter of Ezh2 wild type (n=1093), heterozygous (n=1452), and null (n=517)
organoids per measured genotype. # indicates p<0.0001 using ANOVA.
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4.3

Ezh2 null organoids gain squamous morphology

Organoid cultures were fixed, sectioned and stained for hematoxylin and eosin, CCSP,
KRT5, Acetylated tubulin (ciliated cell marker), Pro-SPC (alveolar type 2 cell marker), EZH2, or
H3K27me3 (Figure 4.5;4.7). When compared to wild-type, there was a significant increase in
Ezh2 null organoids with squamous morphology, characterized by stratified layers of KRT5+ cells
(p=0.0124, Figure 4.8B). Ezh2 null cells tended to form mixed organoids, while wild-type cells
trended more towards a bronchiolar phenotype. However, due to heterogeneity among the
organoid cultures, these results did not meet significance.
By quantitative nuclear immunohistochemistry, EZH2 and H3K27me3 expression levels
were depleted in Ezh2 null organoids compared to wild type (Figure 4.5-4.6). We also quantified
the number of positively stained cells within each organoid and found that Ezh2 null organoids
had fewer acetylated tubulin positive cells, likely due to the decreased numbers of bronchiolar
organoids (Figure 4.8A). These results suggests that Ezh2 deletion could perturb lung cell
differentiation and self-renewal, leading to decreased self-renewal and skewing of organoid
subtype distributions.
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Figure 4.5

Mouse EZH2 and H3K27me3 immunohistochemistry representative images, scale

bar = 100µm.
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Figure 4.6

Mouse EZH2 and H3K27me3 immunohistochemistry analysis.

A) Average percentage of organoid nuclei expressing varying levels of EZH2 from Ezh2 wild-type
(n=3), heterozygous (n=2), and null (n=3) mouse donors.  indicates p=0.016 with a ANOVA
comparing Ezh2 wild-type to Ezh2 null, and ▲ indicates p=0.0012 with a ANOVA comparing
Ezh2 heterozygous to Ezh2 null. B) Average percentage of organoid cells expressing mod-high
levels of EZH2, ** indicates p<0.0032 using ANOVA. C) Average percentage of organoid nuclei
expressing varying levels of H3K27me3 from Ezh2 wild-type (n=3), heterozygous (n=2), and null
(n=3) mouse donors. D) Average percentage of organoid cells expressing high levels of
H3K27me3. Mod-high expression is constituted as staining intensities 4-7, while high levels are
staining instensities 5-7.

60

Figure 4.7

Mouse organoid immunofluourescence representative images, scale bar = 100µm.
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Figure 4.8

Mouse organoid immunofluorescence analysis

A) Average number of cells per organoid expressing basal cell marker, keratin 5 (KRT5), ciliated
cell marker, acetylated tubulin (AcTub), and alveolar type 2 cell marker, surfactant protein C
(SPC). Only organoids that had at least one positive cell for each marker were graphed. B) Average
organoid type, based on IF and H&E stain evaluations of Ezh2 wild type (n=4) and heterozygous
(n=4) and null (n=3) mouse donors, * indicates p=0.0124 using ANOVA comparing Ezh2 wild
type and null.
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CHAPTER 5. EZH2 DEPLETION RESULTS IN DISTINCT TRANSCRIPTIONALLY
DEFINED CELL TYPES IN ORGANOID CULTURES
A cell’s transcriptional profile indicates which genes are being expressed or not expressed
at any given moment. In the laboratory, this expression pattern is determined through the isolation,
quantification and sequencing of messenger ribonucleic acid (mRNA) through a process known as
Single-Cell RNA sequencing (scRNA-seq). In short, a heterogeneous mixture of cells are
separated in order to isolate their mRNA. The mRNA is then reverse transcribed and a
complimentary DNA (cDNA) library is generated. Finally, the comparison of different cDNA
libraries offer insight into unique cell subpopulations and ultimately into potential genetic
variances among healthy and diseased tissues. Thanks to the innovation of scRNA-seq, great
strides have recently been made in the field of pulmonary fibrosis (PF) [60, 62], chronic lung
inflammation [61, 65], and chronic obstructive pulmonary disease ex vivo [64]. In the past, genome
wide location analysis was employed to characterize the transcriptome of 2D cultured, human
embryonic fibroblasts following Ezh2 siRNA transfection [94]. Given that 3D spheroid models
have shown to be more physiologically relevant compared to 2D cultures [108], specifically
regarding noticeable differences in differentiation and proliferation patterns, cell cross talk, and
comparable gene expression patterns to in vivo experiments, we reasoned that transcriptional
analysis of mouse-derived organoids would yield novel findings.

5.1

Single cell RNA sequencing reveals 15 unique cell types in murine lung organoids
To better characterize the heterogeneity of these organoid cultures, singe cell RNA-

sequencing was conducted (Figure 4.1). Analysis of all cells captured from organoids of Ezh2
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wild-type, heterozygous, and null cultures allowed for the identification of fifteen distinct lung cell
populations that were characterized based on the expression of conserved hallmark genes (Table
5.1-5.2; Figure 5.1). Among the identified cells were basal cells, club cells, bronchioloalveolar
stem cells, transitioning basal cells, ciliated cells, replicating and mitotic cells, and dead/dying
cells. Interestingly, we identified a unique population of basal cells that express Trp63 and Itga6,
but had low expression of basal cell keratins Krt5, Krt14 and, in particular, Krt17. We also
identified the recently characterized Krt17+/Krt8+ progenitor cell population that lacked
expression of Krt5, but had strong expression of Fn1 and Ager [60-62, 65].

5.2

Perturbation of Ezh2 expression in vitro drives changes in differentiation patterns
and transcriptional programs
We next examined the proportions of each cell clusters based on Ezh2 genotype (Figure

5.4; 5.6). We found that the Ezh2 wild-type organoids were largely composed of Trp63+/Krt17+
classical basal cells, cycling and transitioning basal cells, Krt8+ progenitor cells, and club cells.
In contrast, Ezh2 null organoids were composed largely of Trp63+/Krt17- basal cells, cycling
BASC, dead/dying cells, and cells transitioning into alveolar type 2 or bronchioalveolar stem cells.
Ezh2 heterozygous cultures contained all cell populations seen in the Ezh2 wild-type and Ezh2 null
cultures. Relative gene expression analysis between genotypes showed a drastic loss in Krt17 and
Sox9 when Ezh2 expression was diminished (p<0.0001, Figure 5.5). Furthermore, loss of Ezh2
expression was accompanied with an increased expression of the alveolar type 2 cell marker,
Lamp3 (p<0.0001), as well as Foxp2 (p<0.0001), which is known to be involved in the
alveolarization of developing mouse lung [126, 127]. Ezh2 null BASC and club cells expressed
higher levels of the goblet cell marker, Muc5ac, than Ezh2 wild type cells (p=0.001). With the
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exception of cells undergoing EMT, Ezh2 wild-type and null cells exhibited significant differences
in proportions of population (Figure 5.6). In particular, Ezh2 null organoids contained
significantly more dead/dying cells, suggesting a mechanism for the decreased organoid selfrenewal.
In order to understand changes in transcriptional programs caused by Ezh2 deletion in the
predominant cell types, rank-ordered lists comparing Ezh2 null to Ezh2 wild type or Ezh2
heterozygous to Ezh2 wild type were constructed. Gene set enrichment analysis or these rankordered gene lists revealed that Ezh2 null organoids had significant enrichment in gene programs
associated with lung development, lung disease, epithelial to mesenchymal transition and lung
cancers (Figure 5.8; Table 5.3). In addition to the same pathways enriched in Ezh2 null cells,
Ezh2 heterozygous organoids also exhibited enrichment of inflammatory response pathways when
compared to Ezh2 wild type (Figure 5.8). To link these results to human samples, we next
generated a list of significantly differentially expressed genes within the Krt17- basal cell
populations by comparing Ezh2 heterozygous to Ezh2 wild type and Ezh2 null to Ezh2 wild type
populations. We compared these gene signatures to a rank ordered gene list from smokers with
severe emphysema compared to healthy smokers [128]. Interestingly, we found that genes highly
enriched in Krt17- basal cells of Ezh2 heterozygous and null organoids were also highly enriched
in emphysemic lungs (Figure 5.9). These data show the heterogeneous outcomes of depleting
PRC2 activity while challenging lung stem and progenitor cells to proliferate and differentiate and
suggest that Ezh2 deficiency greatly decreases Krt17+ cell types including classical basal cells and
Krt8+ progenitor cells. Furthermore, these changes in transcriptional states are enriched in human
COPD patients [64]. Finally, in order to link our findings in the murine lung organoids to CBS
over-expression in the human system, we generated rank ordered gene lists of Ezh2 null vs wild
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type, Krt17- and Krt17+ basal cell clusters and compared them to significantly differentially
expressed genes of CBS overexpressing HBECs. Interestingly, gene set enrichment analysis
revealed that genes highly expressed in CBS overexpressing HBECs were also highly enriched in
Ezh2 null, Krt17+ and Krt17- basal cells (Figure 5.10).
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Table 5.2

Reference Numbers for Table 5.1
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Figure 5.1

Subpopulations Heat Map

Heat map depicting differential gene expression among the 15 identified cell populations. Yellow
indicates highly expressed. Heat map was generated by Xufeng Qu and Jinze Liu.
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Figure 5.2

Subpopulations Umap

UMAP plot of Ezh2 wild type, heterozygous, and null organoids annotated with their identified
cell types and representative cartoon. Umap was generated by Xufeng Qu and Jinze Liu.
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Figure 5.3

Subpopulations Dot Plot

Dot plot showing the relative expression of marker genes (x-axis) and their respective cell types
(y-axis). Representative cell types are positioned below their respective gene hallmarks. Dot plot
was generated by Xufeng Qu and Jinze Liu.
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Figure 5.4

Subpopulations Distribution Umap

UMAP plot of Ezh2 wild type, heterozygous, and null organoids showing a heterogeneous
distribution of cell clusters across genotypes. UMap was generated by Xufeng Qu and Jinze Liu.
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Figure 5.5

Gene Expression Violin Plots

Violin plots showing the relative abundance of gene expression across genotypes. # indicates
adjusted p<0.0001 comparing wild type to null organoids. Relative Muc5ac expression was
quantified in club and basal cells. ** indicates p=0.001 comparing Ezh2 wild type to Ezh2 null
organoids. Expression plots were generated by Xufeng Qu and Jinze Liu.
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Figure 5.6

Subpopulations Distribution Bar Graph

Bar graph showing the distribution of cell clusters across genotypes. # indicates adjusted p<0.0001
for ratio differences based on z-test. Bar plot was generated by Xufeng Qu and Jinze Liu.
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Figure 5.7

Subpopulations Distribution Umaps with Trajectories

Annotated Uniform Manifold Approximation and Projection (UMAP) plots showing distinct
differences in cell clusters and trajectories across genotypes. Umaps were generated by Xufeng
Qu and Jinze Liu.
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Figure 5.8

Select Subpopulations Enrichment Score Maps

A) Dot plot showing gene normalized enrichment scores (y-axis) and false discovery rates
(bubble size) between Ezh2 heterozygous and wild type clusters. B) Dot plot showing gene
normalized enrichment scores (y-axis) and false discovery rates (bubble size) between
Ezh2 null and wild type clusters.
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Figure 5.9

Organoids and Human Lung Tissue V. Organoids Gene Set Enrichment Analysis

Gene set enrichment analysis showing similarities in transcription profiles of Krt17- basal cells in
mouse organoids and emphysema human lung.

78

Figure 5.10

Human Bronchiolar Epithelial Cells V. Organoids Gene Set Enrichment Analysis

GSEA showing similarities in transcription profiles of Krt17+ and Krt17- null mouse organoids
and HBECs overexpressing CBS (CBS OE). RNA sequence analysis on CBS overexpressing
organoids was conducted by Jinpeng Liu.
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CHAPTER 6. EZH2 HETEROZYGOUS MICE EXPOSED TO OVALBUMIN EXHIBIT
INCREASED BRONCHIOLAR RESPONSE
Inflammation is a major pathological entity of COPD, and ovalbumin inhalation by mice
elicits a phenotype similar to COPD, noted with temporary epithelium wall thickening and goblet
cell secretion [129]. Given that epigenetic modifications is a plastic phenomenon that occurs over
time, we decided to employ murine models to evaluate the role of EZH2 in epithelial cell resolution
following allergic inflammation.

6.1

Mouse lung analysis elucidates the effects of dose dependent gene expression in vivo
In order to elucidate how Ezh2 expression alters bronchiolar lung cell fate decisions in vivo,

we established cohorts of adult mice that were administered doxycycline through ad libitum water
for a period of 4 months (Figure 6.1). We reasoned this was sufficient time for lung epithelial cell
turnover that could be altered in the absence of proper PRC2 function. Tail DNA from these mice
showed nearly complete recombination of Ezh2 (Figure 6.2).
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Figure 6.1

Mouse treatment schematic

Schematic: Ezh2 conditional knockout mice were generated using a Tet-on system. Mice ingested
doxycycline water (Dox Water) ad libitum throughout the experiment, underwent two separate
ovalbumin (OVA) intraperitoneal injections or no OVA injection, then received a single inhalation
treatment of OVA, saline or no inhalation, and were sacrificed the following week.
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Figure 6.2

Mouse Genotype Verification

Gel electrophoresis of Ezh2 wild-type, heterozygous, and null mouse tail DNA showing
recombination of Ezh2 floxed alleles. Culture DNA is from 3D Matrigel, co-cultured Ezh2 null
bronchioalviolar stem cells and neonatal mouse lung endothelial cells treated with doxycycline
(+Dox) and without (-Dox).
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6.2

Ovalbumin significantly up regulates mucus secretion and lung epithelium width in
Ezh2 heterozygous mice
To investigate the role of PRC2 in how bronchiolar lung epithelium responds to

inflammatory signals and how the epithelium resolves after this response, we sensitized mice by
injecting ovalbumin (OVA), challenged mice with aerosolized OVA, and conducted
immunostaining on the whole lung (Figure 6.3;6.4;6.7). In non-challenged mice, there were no
obvious differences in bronchiolar lung epithelial morphology among the three Ezh2 genotypes.
When examining the OVA-challenged mice, we first noticed that the bronchiolar epithelium of
Ezh2 wild type and heterozygous mice showed signs of an allergic response to OVA, while the
epithelia of Ezh2 null mice did not. Given that our approach was not tissue or cell specific, this
result is consistent with a loss of OVA response in mice where Ezh2 has been depleted in T cells
[130]. Despite the lack of OVA response in Ezh2 null mice, Alcian Blue staining revealed that
OVA challenged Ezh2 heterozygous mice were the only genotype to exhibit a very significant
increase in mucin production in the bronchiolar epithelium when compared to OVA challenged
Ezh2 null mice (p=0.0009, Figure 6.5). Furthermore, bronchiolar lung epithelium was
significantly wider in OVA challenged Ezh2 heterozygous mice when compared to OVA
challenged Ezh2 null (p=0.0012) mice (Figure 6.6).
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Figure 6.3

Mouse lung H3K27me3 and EZH2 immunohistochemistry analysis

A) Average percentage of epithelial cells expressing moderate to high levels of EZH2, * indicates
p<0.041 using ANOVA comparing ovalbumin challenged Ezh2 wild type to Ezh2 null and Ezh2
heterozygous to Ezh2 null. B) Average percentage of cells expressing moderate to high levels of
H3K27me3. Analysis is based on Ezh2 wild type (n=6), heterozygous (n=11), and null (n=5) that
received saline or were no challenge, and Ezh2 wild type (n=9), heterozygous (n=10), and null
(n=6) mice that received OVA challenge. Throughout, WT indicates Ezh2 wild-type, Het indicates
Ezh2 heterozygous and Null indicates Ezh2 null.

84

Figure 6.4

Mouse lung Alcian Blue stain representative images

Representative images of whole mouse lung Alcian Blue stains, scale bar = 100µm.
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Figure 6.5

Mouse lung Alcian Blue stain analysis

Average area of Alcian Blue stain within mouse lung epithelium, *** indicates p=0.0009 using
ANOVA comparing ovalbumin challenged Ezh2 heterozygous to ovalbumin challenged Ezh2 null.
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Figure 6.6

Mouse lung bronchiolar epithelium width analysis

Average width of bronchial epithelium, *** indicates p<0.0001 using ANOVA comparing
ovalbumin challenged Ezh2 heterozygous to ovalbumin challenged Ezh2 null.
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6.3

Partial loss of Ezh2 expression is associated with aberrant club and goblet cell
differentiation
Compared to Ezh2 wild type and Ezh2 null mice, OVA challenged Ezh2 heterozygous mice

possessed a significantly higher number of MUC5AC+ cells (p=0.0494, p<0.0001) and CCSP+
cells (p=0.0069, p<0.0001) in the bronchiolar epithelium (Figure 6.8).

Consistent with a

transdifferentiation of club cells to mucus producing cells, OVA challenged Ezh2 heterozygous
mice also had significantly higher percentages of MUC5AC+/CCSP+ cells compared to Ezh2 null
mice (p=0.0019, Figure 6.8).

6.4

Ovalbumin significantly up regulates EZH2 expression

Quantitative immunohistochemistry showed that EZH2 expression was increased by OVA
challenge, and that as expected, EZH2 expression was significantly lower in OVA challenged Ezh2
null mouse lung epithelium compared to Ezh2 wild type and Ezh2 heterozygous (p=0.04).
However, H3K27me3 levels did not change as dramatically, which could be due to a lack of
proliferation in the Ezh2 null lungs leading to build up of the epigenetic mark (Figure 6.3).
Together, these data indicate that Ezh2 heterozygous mice have an exacerbated response to OVAchallenge and this may mimic the PRC2-low state observed in bronchiolar epithelial cells of COPD
patients.
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Figure 6.7

Mouse lung immunofluorescence representative images

Representative images of immunofluorescence stain of Keratin 5 (KRT5), club cell secretory
protein (CCSP), and Mucin 5AC (MUC5AC), scale bar = 100µm. Immunofluorescence analysis
was conducted by Tanner Ducote
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Figure 6.8

Mouse lung immunofluorescence analysis

A) Average number of CCSP+ cells, ** indicates p=0.0069 using ANOVA comparing ovalbumin
challenged Ezh2 wild type to ovalbumin challenged Ezh2 heterozygous, *** indicates p=0.0002
using ANOVA comparing ovalbumin challenged Ezh2 heterozygous to ovalbumin challenged
Ezh2 null. B) Average number of MUC5AC+ cells, * indicates p=0.0494 using ANOVA test with
equal variance comparing ovalbumin challenged Ezh2 wild type to ovalbumin challenged Ezh2
heterozygous, *** indicates p<0.0001 using ANOVA test with equal variance comparing
ovalbumin challenged Ezh2 heterozygous to ovalbumin challenged Ezh2 null. C) Average number
of MUC5AC+/CCSP+ cells, ** indicates p=0.0019 ANOVA test with equal variance comparing
ovalbumin challenge Ezh2 heterozygous to ovalbumin challenge Ezh2 null. Analysis is based on
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Ezh2 wild type (n=6), heterozygous (n=10), and null (n=6) that received saline or were no
challenge, and Ezh2 wild type (n=9), heterozygous (n=10), and null (n=6) mice that received OVA
challenge. Throughout, WT indicates Ezh2 wild-type, Het indicates Ezh2 heterozygous and Null
indicates Ezh2 null.
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CHAPTER 7. SUMMARY AND FUTURE DIRECTIONS
In this study, we sought to elucidate the role of Polycomb Repressive Complex 2 (PRC2)
in adult lung stem cell fate. We show that loss of PRC2 activity was strongly associated with
COPD lung pathophysiology such as basal and goblet cell hyperplasia. Complete knockout of Ezh2
in adult mouse lung organoid cultures led to a loss in stem cell self-renewal capabilities and gain
of squamous morphology. scRNA-seq analysis revealed that full loss of Ezh2 resulted in the
accumulation of a newly identified Krt17- basal-like cell, and a decrease in classical basal stem
cells, club cell progenitors, and alveolar transition cells. On the other hand, partial loss of Ezh2
results in increased expression of inflammatory genes while complete loss of Ezh2 does not.
Furthermore, partial Ezh2 expression in ovalbumin challenged mice resulted in mimicry of COPD
traits in the lung such as increased club to mucus cell transdifferentiation, increased MUC5AC
expression, and thickened epithelium. Finally, we established a strong association between CBS
expression and aberrant secretory cell differentiation in COPD lung, and showed that its
overexpression may interfere with PRC2 activity. Taken together, our data suggests that PRC2 is
integral to facilitating proper lung stem cell differentiation in adult humans and mice.
It is notable that the organoid cultures that we established from murine lung epithelial cells
shared numerous cell populations with those recently identified by scRNA sequencing in patient
lung samples. Analysis of pulmonary fibrotic (PF) lung unveiled the presence of an aberrant
basaloid cell population that were KRT17+/KRT5-, likely derived from club and AT2 cells, that is
involved along the alveolar type 1 (AT1) terminal differentiation pathway [60, 62]. Similarly,
evaluation of bleomycin-induced PF mouse lung led to the identification of a Krt8+ population
that were also derived from club and AT2 cells and involved in AT1 terminal differentiation.
Notably, mimicry of chronic inflammation, through sustained Il-1β treatment, halted AT1
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differentiation and led to the accumulation of these intermediate cells [61, 65, 131]. These
populations are likely overlapping with a consensus phenotype of KRT5-/KRT17+/KRT8+/FN1+
and increased cellular senescence. Our finding that Ezh2 null organoids have a significant loss in
a Krt5-/Krt8+/Krt17+/Fn1+ cell population suggests that Ezh2 expression may be a key
contributor toward the pathology of pulmonary fibrosis. A recent paper showed that inhibition of
EZH2 through the inhibitor GSK126 was able to abrogate TGFβ-induced lung fibrosis phenotypes,
and our organoid model presents additional cellular mechanistic insight into this phenomenon
[132].

Furthermore, the increased expression of AT2 marker Lamp3, and the alveolar

developmental marker Foxp2 suggests that loss of Ezh2 expression could serve as a potential
therapeutic avenue to restore proper alveolar regeneration. However, the drastic loss in a key distal
airway repair transcription factor, Sox9, infers that additional evaluation is needed to fully
elucidate the role of Ezh2 expression on alveolarization.
One of our most interesting findings is the stark contrast in Krt17 expression between Ezh2
wild-type and null organoids, where Krt17+/Trp63+/Krt5+ classical basal cells were predominate
in Ezh2 wild-type and Krt17-/Trp63+/Krt5- basal-like cells were predominate in Ezh2 null
organoids. Previous studies have identified an intrapulmonary Trp63+/Krt5- progenitor population
that initially resides in mouse airway, but upon exposure to H1N1 influenza virus, migrates to the
alveolar region and forms ectopic Trp63+/Krt5+ bronchiolar-like epithelia “pods” [133, 134]. The
phenomenon of bronchiolization has been previously observed in idiopathic PF lung [135, 136],
and the expansion of KRT5+ cells is believed to occur in response to severe lung injury, after AT2
and AT1 populations have been extensively destroyed [137]. TP63+/KRT5+ pods have also been
identified in the lungs of Acute Respiratory Distress Syndrome patients diagnosed with Diffuse
Alveolar Damage [138], which are two diseases commonly observed in SARS-CoV-2 (COVID93

19) infected patients [139-141]. Again, our data suggest a lack of differentiation of this cell type
and rather an accumulation of the precursor Krt17-/Trp63+/Krt5- cells, suggesting that Ezh2 may
be integral to allowing proper differentiation of these cells.
Inflammation is a major pathological entity of COPD, and ovalbumin inhalation by mice
elicits a phenotype similar to COPD, with noted temporary epithelium thickening and increases in
goblet cells [129]. OVA-challenged Ezh2 heterozygous mice exhibited a more robust bronchiolar
phenotypes than Ezh2 wild-type mice. Similarly, gene enrichment pattern analysis revealed that
Ezh2 heterozygous organoids expressed more inflammatory-associated genes than Ezh2 wild-type
organoids. These data suggests that epithelial cells with diminished Ezh2 expression could amplify
and exacerbate the immune response observed in COPD lung. Previous literature has demonstrated
that genetic deletion of Ezh2 in CD4+ T cells prevented their clonal expansion in vivo and
prevented ovalbumin response [130], and given the model we chose, we believe deletion of Ezh2
in immune cells may account for the diminished immune response observed in the Ezh2 null mice.
In order to determine the role of Ezh2 specifically in epithelial cell resolution following allergic
inflammation, we are in the process of generating a CC10-CreER, Ezh2 floxed mouse strain [142].
Lastly, we observed a strong decrease in H3K27me3 in COPD bronchiolar epithelium, and
importantly, the percentages of H3K27me3-high cells significantly correlated with fewer KRT5+,
MUC5AC+ and MUC5AC+/CCSP+ cells. This is in contrast to a study that revealed a
significantly higher number of H3K27me3 cells in COPD lung. These data could represent
differences in patient populations, or also be due to the differences in analysis as we measured
stain per nucleus and the former study measured positive cells per basement membrane length.
Our data are supported by findings in other mouse models of PRC2 deficiency where aberrant
expression of KRT5+ and mucins cells were observed [103, 104, 143, 144]. Similarly, our previous
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work has found that lung squamous cell carcinomas, which can typically be characterized as
KRT5+, have a marked loss of H3K27me3 levels when compared to adenocarcinomas [145].
Given that squamous lung cancer is more common in COPD patients [146], this finding could help
us to better understand and address the increased prevalence of squamous lung cancers in our home
state of Kentucky [147]

Finally, although high CBS expression has already been observed in

COPD lung [105], we report a strong positive correlation between its expression and aberrant
epithelial cell differentiation. Additionally, we show that a substantial increase in CBS expression
yields significantly lower EZH2 and KRT17 expression in vitro. These findings, coupled with the
strong negative correlations observed between H3K27me3 and aberrant cell differentiation, imply
a close relationship between methionine cycling and gene expression patterns in human tissue.
The transcriptional profile similarities shared between the Ezh2 knockout organoids and CBS
overexpressing HBECs offers a promising avenue for understanding how reactive oxygen stress
could influence epigenetic programming in lung epithelium.
Based on a comprehensive evaluation of our findings, we offer a working hypothesis which
demonstrates a relationship between PRC2 activity, CBS expression, and aberrant bronchiolar cell
differentiation (Figure 7.1). Patient derived tissue analysis reveals that a loss in PRC2 activity and
gain in CBS expression leads to increased instances of bronchiolar cell transdifferentiation and
basal cell metaplasia. Furthermore, mouse lung organoid analysis reveals that ample loss of EZH2
expression leads to the appearance of squamous organoids and the enrichment of Krt17- basal-like
cells whose transcriptional programs match that of CBS-overexpressing human bronchiolar
epithelial cells.
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Figure 7.1

Working Hypothesis Schematic

The high expression of CBS and low abundance of H3K27me3 are both correlated with
aberrant bronchiolar epithelium phenotypes. Loss of PRC2 activity and gain in CBS
expression correlates with club-goblet cell transdifferentiation and metaplasia of goblet and
basal cells in human lung. Reduction of H3K27me3 through deletion of EZH2 in mousederived organoids leads to the morphological development of squamous organoids,
accumulation of BASC/AT2 cells, and emergence of Krt17- basal cells. Similarly,
overexpression of CBS in human bronchiolar epithelial cell lines reduced EZH2 expression
and H3K27me3 levels, and engendered cells that were transcriptionally similar to Ezh2
null basal cells. Additionally, partial knockout of Ezh2 led to a drastic increase in
inflammatory response gene expression while complete knockout led to a drastic decrease
in a Krt8+ progenitor cell population that is believed to persist in the parenchyma of
pulmonary fibrotic lung.
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Restoring PRC2’s ability to repress lineage specific genes serves as a promising therapeutic
target to induce proper stem cell differentiation in COPD lung. Additionally, further
characterization of the role of PRC2 in lung stem and progenitor cells will have a vertical impact
on potential therapeutic interventions for diseases rooted in cell reprogramming; i.e. lung cancer
and pulmonary fibrosis.
Two of the most intriguing discoveries from this study was the emergence of the Krt17basal cell variant in Ezh2 heterozygous and null organoids, and the diminished expression of
inflammatory response genes observed in Ezh2 null organoids compared to heterozygous. Because
basal cells were the most prominent cell population in all genotypes, it prompts the questions: 1.
What is the critical mass of EZH2 expression that allows for maintenance of normal basal cell
identity? 2. What concentration of EZH2 expression promotes diminished expression of
inflammatory response genes? 3. Is there an ideal concentration of EZH2 expression that could
allow for the expansion of a less immunogenic basal cell population and could Krt17 be a
biomarker for this unique cell type? To address these questions, future work could utilize the FDA
approved global EZH2 inhibitor, EPZ-6438, in cell differentiation assays. One possible experiment
would be to grow human bronchial epithelial cells as air liquid interphase cultures, treat with
gradually increasing doses of EPZ-6438, induce differentiation, and then quantify cell fate, KRT17
expression levels, and H3K27me3. Additionally, one could treat these differentiated cells with
allergens then examine their ability to produce various chemokines, cytokines and endogenous
danger signals. Ideally, further characterization of KRT17- basal cells could provide a potential
therapeutic avenue for combating chronic inflammation in COPD lung and offer insight into the
effects of the global EZH2 inhibition on lung cell differentiation.
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Given that we have demonstrated a relationship between CBS overexpression, PRC2
dysfunction, and aberrant lung epithelial cell differentiation, interrogation of potential therapeutic
interventions is appropriate. One potential intervention could be diminishing methionine intake,
as previous literature has shown that a low methionine diet can decrease CBS protein levels, which
may lead to an increase in SAM availability, by way of homocysteine metabolism modulations
[148-150]. CBS can be inhibited by aminooxyacetic acid (AOAA). This small molecule is a
nonselective inhibitor of Pyridoxal 5′-phosphate (PLP)-dependent aminotransferases and is
primarily utilized as a tool compound for the suppression of tumor cell proliferation in basic
science experiments [151, 152]. However, because PLP enzymes are critical for stabilizing
numerous amino acid biosynthetic and degradation pathways in humans, the therapeutic window
for treating COPD would likely be too small for commercial use [153]. Alternatively, utilization
of GSK-J4[154], a selective inhibitor for the H3K27 demethylases JMJD3/UTX, would be useful
to maintain PRC2 activity and ultimately allow for re-normalization of the lung epithelium
overtime.
One popular theory of aging states that the gradual decline in organ function is due to a
natural decrease in stem cell self-renewal and division rates overtime [155]. COPD is largely
considered a disease of an aging lung, with prevalence significantly increasing after the age of 60
and the mean patient age being 71 [156, 157]. Notably, histone methylation is a process largely
employed during S phase with H3K27me3 being fully complete following the G1 phase, after cells
have divided [158]. Thus, if we adopt the notion that lung stem cell activity decreases overtime, it
will also be beneficial to understand how PRC2 activity changes. To this end, I propose a mouse
study that seeks to characterize PRC2 activity and function in mature, middle aged, and old mice.
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Additionally, episodically or chronically exposing these mice to noxious agents will help to
elucidate how, and to what degree, environmental agents influence PRC2-mediated stem cell fate.
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VITA
Education




University of Kentucky, Lexington, KY
[2016-Present]
Doctor of Philosophy- Toxicology and Cancer Biology (GPA: 3.8)
North Carolina Agricultural and Technical State University, Greensboro, NC
[2013-2015]
Master of Science Degree- Biology (GPA: 4.0)
Albany State University, Albany, GA
[2007-2011]
Bachelors of Science Degree-Biology
Biotechnology concentration

Research Experience






Graduate Student
[August 2016-Present]
Location: University of Kentucky
Principle Investigator: Christine Fillmore Brainson
Project: Elucidate the epigenetic mechanisms that lead to chronic obstructive pulmonary disease
(COPD) and other lung diseases such as squamous cell carcinoma. I am using a mouse model of
deletion of the histone methyltransferase EZH2, sorting mouse lung stem and progenitor cells and
deleting EZH2 in vitro, staining human COPD and normal lung sections, and using human air-liquidinterface cultures to knock-down EZH2.
Laboratory Assistant
[July 2015-August 2016]
Location: Emory University
Principle Investigator: Dr. Edward Morgan
Project: Understand how nitric oxide affects cytochrome P450, CYP51A1 degradation. I executed
cell culture techniques, dose and time dependent experiments, western blot analyses, and cell
transduction.
Research Scientist
[May 2013-June 2015]
Location: North Carolina Agricultural and Technical State University, Greensboro, NC
Principle Investigator: Dr. Jessica Han
Project 1: Investigate brain iron mishandling as a potential contributor to neurodegeneration in
obesity models by determining the effects of high fat diet on regional brain iron and ferritin (a good
indicator of iron biology) and alpha synuclein (a protein linked with neurodegenerative processes)
protein expression. I worked with C57BL/6J mice for ~17 weeks. After which, collect blood and
organs and conduct western blot of iron response proteins, triglyceride concentration assay,
hemoglobin concentration assay, hematocrit, Insulin tolerance test, ELISA and
immunohistochemistry. Additionally, gain literary knowledge in obesity, iron content and
neurodegenerative diseases.
Project 2: Investigate brain iron content and behavior in dietary-induced obesity developing mice.
I conducted atomic absorption spectrometry and home-cage scan behavior analysis.
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Graduate Research Assistant; Accountability for Cancer Care through Undoing Racism and Equity
(ACCURE) Study
[July 2013-September 2013]
Location: Moses Cone Memorial Hospital, Greensboro, NC/University of North Carolina at Chapel
Hill, Chapel Hill, NC
Co-Principle Investigators: Dr. Sam Cykert and Dr. Geni Eng
Project: Clinical trial that aimed to increase transparency and accountability in the health care
system in an effort to reduce racial inequities in cancer treatment outcomes. I successfully
recruited and consented patients to the study, refined intervention components, conducted
database maintenance, successfully navigated through the electronic medical record review,
gained literary knowledge on breast and lung cancer, successfully completed racial equity training,
interpreted magnetic resonance imaging (MRI) and positron emission tomography (PET) scans,
Attended multidisciplinary breast and lung cancer clinic, successfully determined breast and lung
cancer stages.
Research Assistant; GEMM Study: A Risky Sex Prevention for African American Adolescent Girls
[May 2013-June 2013]
Location: University of North Carolina at Greensboro, Greensboro, NC
Principle Investigator: Dr. Robin Bartlett
Project: Investigated the feasibility and efficacy of HIV prevention intervention for black adolescent
girls. Specifically examining the role that racial pride plays in this intervention process and how it
affects risky sexual behavior. Successfully completed CITI training. Conducting data collection, data
coding and input, assist PI in delivering interventions and control conditions. Gain knowledge in
cultural competence, participation consent and assent contracts, HIV knowledge, health literacy
and public health research protocols.
Student Research Assistant; Biomass to Energy Project
[September 2011-June 2012]
Location: Albany State University, Albany, GA
Principle Investigator: Dr. Kwaichow Chan
Project: Identified gasification systems around the world to potentially collaborate with and
provide an alternative fuel for the city of Albany, Georgia. Researched various gasification systems
around the world, crafting surveys, conducting phone interviews, creating power point
presentations.
Summer Intern; Health Education Research Opportunities (HERO) Program
[June 2011-August 2011]
Location: Virginia Commonwealth University, Richmond, VA
Principle Investigator: Dr. Daniel Conrad (Doctoral candidates: Sarah Norton, Sheinei Saleem)
Project: Identified the role of myeloid-derived suppressor cells (MDSC) in asthma. Worked with
C57BL/6J mice for ~9 weeks. Induced allergenic response through intraperitoneal and intranasal
injections. After which, measured bronchoconstriction using the flexivent system collected blood
bronchoalveolar lavage (BAL) fluid, cardiac blood, fixed and extracted lungs and heart from mice.
Additionally, counted cells with hemocytometer, conducted IgE ELISA, Isolated mast cells,
harvested spleens, and identified cells through flow cytometry.
Summer Intern; Bioinformatics and biotechnology Summer Internship (BBSI) Program
[June 2010- August 2010]
Location: Virginia Polytechnic Institute and State University, Blacksburg, VA
Principle Investigator: Dr. Christopher Lawrence (Doctoral candidate: Ha Dang)
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Project: Conducted laboratory based proteomics by annotating allergenic proteins that trigger
severe immune responses in asthmatics. Utilized state-of-the-art computational sciences to
understanding complex biological systems such as genomics, and proteomics. Advanced analytical
tools include NCBI, ClustalW, Swissprot, Ensmbl, and BLAST to identify and annotate allergenic
proteins.

Publications
Journal Papers
 Jian Han, Justin Plummer, Lumei Liu, Aria Byrd, Michael Aschner & Keith M. Erikson. (2017). The impact
of obesity on brain iron levels and α-synuclein expression is regionally dependent. Nutritional
Neuroscience, 0,0. PMID: 29034829
 Ji Won Park, Aria Byrd, Choon-myung Lee, Edward T. Morgan. (2017). Nitric oxide stimulates cellular
degradation of human CYP51A1, the highly conserved lanosterol 14α-demethylase. Biochemical
Journal, 747,19. PMID: 28830911
 Liu, L., Byrd, A., Plummer, J., Erikson, K. M., Harrison, S. H., & Han, J. (2016). The Effects of Dietary Fat
and Iron Interaction on Brain Regional Iron Contents and Stereotypical Behaviors in Male C57BL/6J
Mice. Frontiers in Nutrition, 3, 20. PMID: 29034829
 Fan Chen, Xiulong Song, Tanner J. DuCote, Aria L. Byrd, Christine F. Brainson. EZH2 inhibition confers
PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition. Cancer Letters June 2021.
Published Abstracts/Presentations at Professional Conferences
 Byrd A, Chen F, Zhao Y, Edgin A, Kim C, Brainson C. “Squamous cell cancers and chronic obstructive
pulmonary disease share Polycomb Repressive Complex 2 dysregulation”.
o American Association for Cancer Research. Atlanta, GA. March 30-April 4, 2019 (Poster)
o Experimental Biology Conference. Orlando, FL. April 6-9, 2018 (Poster)
o UK Toxicology and Cancer Biology Department Retreat. Lexington, KY. August 23, 2019 (Poster)








Byrd A, Chen F, Zhao Y, Edgin A, Kim C, Brainson C. Loss of Polycomb Repressive Complex 2 impairs lung
bronchiolar cell growth and underlies chronic obstructive pulmonary disease. 57th Annual Society of
Toxicology Conference. San Antonio, TX. March 11-15, 2018
o Markey Cancer Center Research Day. Lexington, KY. May 9, 2018 (Poster)
o International Society for Stem Cell Research Conference. Melbourne, Australia. June 20-23,
2018 (Poster)
o The Lung Epithelium in Health and Disease Conference. St. Bonaventure, NY. July 29-August 3,
2018 (Poster)
Byrd A, Park J, Lee C, Morgan E T. Nitric Oxide Stimulates CYP51A1 Down Regulation. 35th Annual
Federation of American Societies for Experimental Biology (FASEB). San Diego, CA April 2-6, 2016
(Poster)
o 11th Annual Great Lakes Drug Metabolism and Disposition Group Meeting. Chicago, IL. May 56, 2016 (Oral)
Byrd A. Plummer J, Erikson K, Han J. Dietary-Induced Obesity Disturbs Iron Homeostasis and AlphaSynuclein Expression in C57BL/6J Mouse Brains. 34th Annual Federation of American Societies for
Experimental Biology (FASEB). Boston, MA. March 28-April 1, 2015 (Poster)
o 3rd Annual Emory University-Laney Graduate School STEM Research Career Symposium.
Atlanta, GA. March 25-26, 2015 (Oral)
Byrd A, Liu L, Cao W, Erikson K, Han J. Interaction of Dietary Iron and Fat on Glucose Clearance. 33rd
Federation of American Societies for Experimental Biology (FASEB). San Diego, CA April 26-30, 2014
(Poster)
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Byrd A, Saleem S, Norton S, Conrad D. Role of Myeloid-Derived Suppressor Cells in Asthma 11th Annual
Biomedical Research Conference for Minority Students (ABRCMS). St. Louis, MO, November 9-12, 2011
(Poster)
Byrd A, Dang H, Babiceanu M, Lawrence C. Unlocking the Alergome of the Airborne Fungus Alternaria
Alternata.
o 24th Annual the Association of Minority Health Professions Schools (AMHPS) symposium.
Newport News, VA. March 25-27, 2011 (Poster)
o 18th Annual Florida-Georgia Louis Stokes Alliance for Minority Participation (FGLSAMP)
Conference. Jacksonville, FL. February 3-6, 2011 (Poster)
o 24th Annual Biomedical Research Conference for Minority Students (ABRCMS). Charlotte, NC.
November 10-13, 2010 (Poster)

Enrichment Experiences






The University of Kentucky Center for Appalachian Research in Environmental Sciences (UK CARES)
Faculty Fellows in Science Communication Auditor
[September 2020-May 2021]
Location: Virtual Program
Responsibilities: This program is designed to provide faculty with skills training for communicating
science to a broader audience, leading to an enhanced capability for outreach and success in
research, teaching, and service.
American society for biochemistry and Molecular Biology’s inaugural (ASBMB) Advocacy Training
Program Delegate
[June 2018-December 2018]
Location: Virtual program
Responsibilities: Received extensive training on how to be effective advocates for science and
scientific research, whether that be at a community, state or federal level. I met with congressional
staff members to advocate for an amendment of H.R. 5119, also known as the Partnership for
Progress and Prosperity (P3) Act, to give special consideration to schools and universities that
integrate substantial political literacy education into their STEM curriculum.
10th Annual NIH Career Symposium attendee

[May 11, 2017]
Location: Bethesda, Maryland






Teaching Assistant
[January 2013-May 2013]
Location: North Carolina Agricultural and Technical State University, Greensboro, NC
Supervisor: Calisha Petty
Responsibilities: Conducted and prepared laboratory lectures and experiments, grade exams and
presentations, interact with non-biology major, undergraduate students on an academic level.
Shadowing Intern
[November 2010]
Location: Center for Disease Control- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Atlanta, Georgia
Epidemiologist: Dr. Madeline Sutton
Laboratory Assistant
[May 2010]
Location: Emory University, Atlanta, GA
Principle Investigator: Dr. Nicole Gerardo
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Responsibilities: Executed various laboratory techniques such as preparing aphid DNA for
polymerase chain reaction, preparing media, bacterial and fungal in vitro bioassays, and capturing
and maturing stink bugs.
Laboratory Assistant
[May 09-July 09]
Location: Albany State University, Albany, GA
Principle Investigator: Dr. Ashok Jain
Responsibilities: Sub-cultured rose plants, sterilized lab instruments, successfully executed the
procedures in formulating root and stem media
Dental Assistant
[June 2005-July 2005]
Location: Smile Success Dental Center, Bellwood, IL
Supervisor: Dr. Mimi Johnson
Responsibilities: Assisted the dentist and hygienist with dental restorations, cleaning impressions,
and radiographs, prepared operatories, and sterilized instruments

Honors, Awards, and Scholarships
2021
2020
2019
2019
2019
2019
2018
2018
2018
2018;2019
2018
2016-2019
2015-2016
2015
2014-2015
2014-2015
2014
2013-2014
2013-2015
2013
2011

Southern Regional Education Board Doctoral Scholars Fellowship
National Heart Lung and Blood Institute (NHLBI) F31 Fellowship Award
Women in Medicine and Science (WIMS) Rising Star Award
Experimental Biology "Scientific Highlights" collaborative poster recognition
American Association for Cancer Research (AACR) Minority Scholar in
Cancer Research Award
Distinguished Speaker for IdeaFestival Bowling Green at Western Kentucky University
Delegate for American society for biochemistry and Molecular Biology’s inaugural (ASBMB) Advocacy
Training Program
$500 poster presentation award for FASEB Lung Epithelium in Health and
Disease Meeting
T-32 Molecular Mechanisms of Toxicity Training Fellowship
$1000 Center for Graduate and Professional Diversity Initiatives, Student Professional Development
Funds
Finger Lakes Environmental Film Festival Diversity Scholars Fellowship (FLEFF)
Lyman T. Johnson Diversity Award
T-32 NIH Diversity grant supplement
Laney Graduate School STEM Research and Career Symposium Travel Award
North Carolina A&T State University tuition waver
T-32 Basic Immune Mechanisms Training Fellowship
FASEB/MARC Travel Award
T-32 Basic Immune Mechanisms Training Fellowship
North Carolina A&T State University tuition waver
Teacher Assistantship at North Carolina Agricultural and Technical State University
1st Place- Poster presentation at Association of Minority Health Professions Schools (AMHPS) conference
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2011 3rd Place- Poster presentation at 2011 Florida-Georgia Louis Stokes Alliance for Minority Participation
(FGLSAMP) Conference
2010 $1000 South East Alliance for Graduate Education and Professorate (SEAGEP) Undergraduate Research
Award
2010 1st place- Outstanding Research Presentation in Albany State University’s 2010 STEM Conference
2007 HOPE Scholarship

Community Service
2020 Panelist: Picture a Scientist: A New Chapter for Women Scientists
2020 Panelist: Mentoring Moments; Graduate School 101
2020 Creator and collaborating coordinator of Secure the Bag project: Initiative aimed at securing
funding to enable the University of Kentucky counseling psychology graduate students to
receive free counseling services. $2,500 seed money secured!
2020 Collaborating Coordinator of New Visions for Black Men: From Maleness to Manhood.
Developed the panel session entitled Melinated Matriculation which explored black men’s
unique journey of getting into- and matriculating through grad/professional school.
2020 36th Annual Kentucky American Water District Science Fair Judge
2020 Creator and Coordinator of The Spectrum: A forum endeavoring to unpack the nuances of
blackness and contextualize those topics through the lens of trying to thrive socially and
professionally in the small college town of Lexington
2020 Lead Coordinator/volunteer: Black Graduate and Professional Student Association
Valentine’s Day fundraising event
2019, 2020 Lead Coordinator/Volunteer for Lexington Regional Science Fair: Mentoring initiative
intended to assist the young men of Carter G. Woodson Academy and Henry Clay High School
prepare for their science poster presentation. All three placed 1st, 2nd, and 3rd place in their
field of study!
2019-2020 Lead Coordinator of 70th Anniversary Celebration Lyman T. Johnson Distinguished Speaker
event: Workshop with Austin Channing Brown discussing the disconnect between franchised
and disenfranchised communities, the implications that this has in academic settings, and
how both communities can contribute to equity in professional (specifically academic) and
social settings. Managed $12,000 account.
2019-2020 Lead Coordinator of monthly personal and professional Development Workshops:
Informative dialogues with the Universities Graduate Student Congress representatives, the
Office of Bias Incident Support Services, James W. Stuckert Career Center, and financial
advisors, in an effort to support them in their desire to thrive during their matriculation in
graduate/professional school.
2019-2020 Lead Coordinator of Monthly "Networking @ Nite" events: Initiative aimed at providing
spaces where marginalized graduate and professional students could come together and
network in a relaxed environment.
2019 Ronald McDonald House breakfast preparation for residents
2019 Lead Coordinator of University of Kentucky Graduate Student Congress’ Mental Health
Awareness Week Keynote address event: Dr. Della Mosley spoke to more than 50 UK faculty,
staff and students about self-care strategies for students of color at historically white
institutions.
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2019 Host of University of Kentucky Graduate Student Congress’ Emergency Town Hall Meeting to
discuss HR.1044/S.386 “Fairness for High Skilled Immigrants Act of 2019” with the graduate,
professional, and post-doctoral community.
2019 Participant in National Association of Graduate-Professional Students (NAGPS) Legislative
Action Day to advocate, on behalf of graduate-professional students, to policy makers at the
federal level.
2019 Hope Lodge dinner preparation volunteer
2019 4th Annual BioBonanza Volunteer
2019 Panelist: I’m Not Your Token; University of Kentucky Center for Graduate and Professional
Diversity Initiatives
2019 Panelist: Building Collaborative Relations; University of Kentucky Graduate Student Life
Summit
2018, 2019 Panelist: Life as a black graduate student at a Predominantly White Institute; University of
Kentucky graduate school
2018 Minorities in Agriculture Natural Resources and Related Sciences (MANRRS) state
competition Oral presentation judge
2017-2019 Summer Undergraduate Research Experience in Environmental Health Sciences (SURES)
Near Peer Mentor
2013, 214 Sister’s Network Inc. Gift for Life Block Walk and Health Fair
2011 Albany State University's Health career fair volunteer
2010 East Albany primary health center's annual health fare volunteer
2009-2010 Girls Inc. volunteer
2009 Albany, Georgia's Daddy Daughter dance volunteer
2006-2007 Helping Our Teen Girls In Real Life Situations (HOTGIRLS) Inc. member

National and International Memberships
2018
2018
2016
2016
2015
2014

American Society for Biochemistry and Molecular Biology (ASBMB)
American Association for Cancer Research (AACR)
American Society for Pharmacology and Experimental Therapeutics (ASPET)
American Physiological Society (APS)
Honor Society of Phi Kappa Phi
Beta Beta Beta National Biological Honor Society

Intramural Memberships
2018, 2019
2019
2019
2009-2011
2009-2010
2009-2010
2007-2010

Black Graduate and Professional Student Association (BGPSA); Secretary, President
Graduate Student Congress; External Affairs Officer
Women in Medicine and Science; Graduate Student Representative
HIV/AIDS Peer Educators; Assistant Secretary
Environmental Science Club; Recycling Committee Chair
Musically Unified Sister In Collaboration (M.U.S.I.C); Sergeant at Arms
Albany State University Marching Ram Show Band; Ms. Classic Touch of Gold
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